Publications by authors named "H-L Zong"
Article Synopsis
- * A clinical trial in China found that 33% of patients treated with tenecteplase had low disability scores after 90 days, compared to 24% of those receiving standard treatment, indicating tenecteplase may be more effective.
- * Safety results showed similar mortality rates (around 13%) for both treatments, but the tenecteplase group had a slightly higher rate of symptomatic intracranial hemorrhage (3%) compared to standard treatment (0.8%).
Background And Purpose: Early neurologic deterioration (END) often occurs during hospitalization in single small subcortical infarction (SSSI). The objective was to identify imaging predictors of END.
Materials And Methods: SSSIs in the lenticulostriate artery within 72 hours of stroke onset from January 2015 to June 2021 were consecutively enrolled.
Background: Omics data may provide a unique opportunity to discover dairy-related biomarkers and their linked cardiovascular health.
Methods: Dairy-related lipidomic signatures were discovered in baseline data from a Chinese cohort study (n=2140) and replicated in another Chinese study (n=212). Dairy intake was estimated by a validated food-frequency questionnaire.
Antibody-drug conjugates (ADCs) are promising therapies for haematological cancers. Historically, their therapeutic benefit is due to ADC targeting of lineage-restricted antigens. The C-X-C motif chemokine receptor 4 (CXCR4) is attractive for targeted therapy of haematological cancers, given its expression in multiple tumour types and role in cancer "homing" to bone marrow.
View Article and Find Full Text PDF